Publications by authors named "Thomas Wehler"

Claim this Profile
S
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Thomas Wehler

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.
Sandra Michaela Ihne-Schubert, Caroline Morbach, Vladimir Cejka, Maximilian Johannes Steinhardt, Aikaterini Papagianni, Thomas Wehler

Clin Res Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO.
Christian Grohé, Thomas Wehler, Tobias Dechow, Sven Henschke, Wolfgang Schuette

Transl Lung Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS.
Nicola Riccetti, Maria Blettner, Katherine Taylor, Beatrice Wehler, Bernhard Gohrbandt, Thomas Wehler

J Cancer Res Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Martin Sebastian, Wilfried E E Eberhardt, Petra Hoffknecht, Martin Metzenmacher, Thomas Wehler

Lung Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Daniel Heudobler, Christian Schulz, Jürgen R Fischer, Peter Staib, Thomas Wehler

Front Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer.
Martin Reck, Thomas Wehler, Francisco Orlandi, Naoyuki Nogami, Carlo Barone

J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug design.
Lina Irsheid, Thomas Wehler, Christoph Borek, Werner Kiefer, Ruth Brenk

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Joerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, Sophie Piperno-Neumann, Annegret Kunitz, Thomas Wehler

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).
Martin Eichler, Marlene Hechtner, Beatrice Wehler, Roland Buhl, Jan Stratmann, Thomas Wehler

Strahlenther Onkol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Marlene Hechtner, Martin Eichler, Beatrice Wehler, Roland Buhl, Martin Sebastian, Thomas Wehler

J Thorac Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Thomas Wehler

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological distress in lung cancer survivors at least 1 year after diagnosis-Results of a German multicenter cross-sectional study.
Martin Eichler, Marlene Hechtner, Beatrice Wehler, Roland Buhl, Jan Stratmann, Thomas Wehler

Psychooncology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical Stability and Biological Variability in MicroRNAs from Dried Blood Spots: A Lung Cancer Therapy-Monitoring Showcase.
Mustafa Kahraman, Thomas Laufer, Christina Backes, Hannah Schrörs, Tobias Fehlmann, Thomas Wehler

Clin Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer.
Thomas Wehler, Michael Thomas, Christian Schumann, Joaquim Bosch-Barrera, Nuria Viñolas Segarra

Lung Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes.
Claudia Pföhler, Michael Klotz, Thomas Wehler, Thomas Vogt, Cornelia S L Müller

Dermatol Ther (Heidelb)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cylindromatosis (Cyld) gene mutation in T cells promotes the development of an IL-9-dependent allergic phenotype in experimental asthma.
Sebastian Reuter, Joachim Maxeiner, Helen Meyer-Martin, Anastasija Michel, Pamela Baars, Thomas C Wehler

Cell Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.
Marc Becker, Claudine Graf, Marcus Tonak, Markus P Radsak, Tobias Bopp, Thomas C Wehler

Oncol Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional diversity of stromal cell-derived factor 1 splice variants in colorectal cancer and melanoma.
Thomas C Wehler, Ksenia Martchenko, Risala H Allami, Marc Becker, Beatrice Wehler

Int J Colorectal Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Jochen Fleckenstein, Alev Petroff, Hans-Joachim Schäfers, Thomas Wehler, Jakob Schöpe

BMC Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Last line therapy with sorafenib in colorectal cancer: A retrospective analysis.
Ksenia Martchenko, Irene Schmidtmann, Thomas Thomaidis, Verena Thole, Peter R Galle, Thomas C Wehler

World J Gastroenterol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.
Risala Hussain Allami, Claudine Graf, Ksenia Martchenko, Beatrice Voss, Marc Becker, Thomas C Wehler

Oncol Lett· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunotherapy in lung cancer: checkpoint inhibitors].
Thomas Wehler, Beatrice Wehler, Ingo Stehle

Dtsch Med Wochenschr· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC inhibitor-loaded bone cement for advanced local treatment of osteosarcoma and chondrosarcoma.
Marcus Tonak, Marc Becker, Claudine Graf, Lukas Eckhard, Matthias Theobald, Thomas C Wehler

Anticancer Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.
Martin Sebastian, Alexandros Papachristofilou, Christian Weiss, Martin Früh, Richard Cathomas, Thomas Wehler

BMC Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis